Kidney TransplantationNCT00498017
Infections After Renal Transplantation: Diseases Pattern in Hong Kong
An observational study of Kidney Transplantation and Infection, run by Hospital Authority, Hong Kong at 2 sites in China.
Trial summary
Infections are the most feared complications developing in patient who had had kidney transplantation. The aim of this study is to document the local disease pattern among this group of patients. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Kidney Transplantation, Infection
- How many people
- 58 participants
- Where
- 2 sitesChina
- Study dates
- Jul 2006to Dec 2007
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Over a period of 4.5 years, between 1/1/2000 and 30/6/2005, there were totally 58 new cases in our renal transplantation clinic. 36 of them were male, 22 of them were female (Male to female ratio is 1.64:1). All were single-organ recipients. Majority of them (57/58 or 98.3%) were receiving their first renal transplantation, the only exception was a women receiving her second renal transplantation during the study period. Majority (57/48 or 98.3%) of them were cadaveric renal transplantation (CRT). One living-related renal transplantation (LDRT) had been performed in Hong Kong during the study period. Majority of the renal transplantation were performed in Mainland China (48/58 or 82.8%), whilst the remaining 10 operations (17.2%) were performed in Hong Kong.
Who may be able to join
- All living-related or cadaveric renal transplantation episodes (including preemptive ones) performed in the Hong Kong Special Administration Region (HKSAR), Mainland China or overseas during the period 1/1/2000 to 30/6/2005
Who cannot join
- multiple organ recipients, incomplete records and lost to follow-up, including those cases who have been taken over by other renal centres
Trial locations and contacts
2 sites in 1 country.
China2 sites
Caritas Medical Centre
Hong Kong
Princess Margaret Hospital
Hong Kong
About this study
Infections are the most feared complications developing in patient who had had kidney transplantation. The aim of this study is to document the local disease pattern among this group of patients.
- Conditions
- Kidney Transplantation, Infection
- Keywords
- Infections
- Medical subject headings
- Infections
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jul 2007 (estimated)
- Study startJul 2006
- Study completionDec 2007
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Kidney TransplantationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 58 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital Authority, Hong Kong
- Sponsor type
- Other government
- Investigators
- Sze Kit Yuen, Dr, Principal investigator, Department of Medicine & Geriatrics, ICU, Caritas Medical Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00498017
- Sponsor's protocol ID
- KW/EX/06-044
- Other IDs
- HARECCTR0500060
- Status last verified
- Jun 2011
- First submitted
- 6 Jul 2007
- Last updated
- 16 Jun 2011
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Infections After Renal Transplantation: Diseases Pattern in Hong Kong
- ClinicalTrials.gov ID
- NCT00498017
- Acronym / sponsor ID
- KW/EX/06-044
- Conditions
- Kidney Transplantation, Infection
- Keywords
- Infections
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 58 participants (estimated)
- Lead sponsor
- Hospital Authority, Hong KongOther government
- Study start
- Jul 2006
- Study completion
- Dec 2007 (actual)
- First posted
- 9 Jul 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Infections are the most feared complications developing in patient who had had kidney transplantation. The aim of this study is to document the local disease pattern among this group of patients.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Over a period of 4.5 years, between 1/1/2000 and 30/6/2005, there were totally 58 new cases in our renal transplantation clinic. 36 of them were male, 22 of them were female (Male to female ratio is 1.64:1). All were single-organ recipients. Majority of them (57/58 or 98.3%) were receiving their first renal transplantation, the only exception was a women receiving her second renal transplantation during the study period. Majority (57/48 or 98.3%) of them were cadaveric renal transplantation (CRT). One living-related renal transplantation (LDRT) had been performed in Hong Kong during the study period. Majority of the renal transplantation were performed in Mainland China (48/58 or 82.8%), whilst the remaining 10 operations (17.2%) were performed in Hong Kong.
Key inclusion criteria (1 listed)
- All living-related or cadaveric renal transplantation episodes (including preemptive ones) performed in the Hong Kong Special Administration Region (HKSAR), Mainland China or overseas during the period 1/1/2000 to 30/6/2005
Key exclusion criteria (1 listed)
- multiple organ recipients, incomplete records and lost to follow-up, including those cases who have been taken over by other renal centres
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2011.
Related trials for Kidney Transplantation
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
RecruitingPhase 2
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
Antibody-Mediated Rejection (AMR)
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Not yet recruitingEarly Phase 1
Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients
Kidney Transplant Recipient
Recruiting
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study
Pediatric Kidney Disease, Transplant;Failure,Kidney
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sze Kit Yuen, Dr principal investigator
Department of Medicine & Geriatrics, ICU, Caritas Medical Centre
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Kidney Transplantation and Infection, run by Hospital Authority, Hong Kong at 2 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2011.